Parametric Portfolio Associates’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $65K | Sell |
24,371
-17,390
| -42% | -$46.4K | ﹤0.01% | 3608 |
|
|
2021
Q4 | $181K | Buy |
41,761
+353
| +0.9% | +$1.53K | ﹤0.01% | 3444 |
|
|
2021
Q3 | $211K | Buy |
41,408
+2,209
| +6% | +$11.3K | ﹤0.01% | 3416 |
|
|
2021
Q2 | $248K | Sell |
39,199
-20,621
| -34% | -$130K | ﹤0.01% | 3326 |
|
|
2021
Q1 | $462K | Sell |
59,820
-38,841
| -39% | -$300K | ﹤0.01% | 3535 |
|
|
2020
Q4 | $646K | Sell |
98,661
-121,471
| -55% | -$795K | ﹤0.01% | 3252 |
|
|
2020
Q3 | $1.46M | Sell |
220,132
-31,343
| -12% | -$208K | ﹤0.01% | 2686 |
|
|
2020
Q2 | $2.1M | Buy |
+251,475
| New | +$2.1M | ﹤0.01% | 2477 |
|